Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis

Author： Pereira Michelly   Cardoso Pablo   Rocha Laurindo   Rêgo Moacyr   Gonçalves Sayonara   Santos Flaviana   Galdino-Pitta Marina   Dantas Andréa   Duarte Ângela   Pitta Maira  

Publisher： Springer Publishing Company

ISSN： 1023-3830

Source： Inflammation Research, Vol.63, Iss.4, 2014-04, pp. : 309-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dose/Exposure‐Response Modeling to Support Dosing Recommendation for Phase III Development of Baricitinib in Patients with Rheumatoid Arthritis

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 6, Iss. 12, 2017-12 ,pp. : 804-813

John Wiley & Sons Inc

Access to resources Recommend Favorite

Durability and Rapidity of Response to Anakinra in Patients with Rheumatoid Arthritis

By Michael H. Schiff  

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2493-2501

Adis International

Access to resources Recommend Favorite

Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-01 ,pp. : 1095-1126

Bentham Science Publishers

Access to resources Recommend Favorite

Rheumatoid Arthritis: Strategies in the Management of Patients Showing an Inadequate Response to TNFα Antagonists

By Lutt Joseph R.   Deodhar Atul  

Drugs, Vol. 68, Iss. 5, 2008-01 ,pp. : 591-606

Adis International

Access to resources Recommend Favorite

Tacrolimus: In Patients with Rheumatoid Arthritis

By Curran Monique P.   Perry Caroline M.  

Drugs, Vol. 65, Iss. 7, 2005-01 ,pp. : 993-1001

Adis International

Access to resources Recommend Favorite